title: Use of DLI to achieve complete donor chimerism in a patient receiving systemic immunosuppression for refractory AIHA post-NST.
authors.forename: P J
authors.initials: PJ
authors.lastname: Hayden
authors.forename: M
authors.initials: M
authors.lastname: Crampe
authors.forename: M
authors.initials: M
authors.lastname: Lawler
authors.forename: E
authors.initials: E
authors.lastname: Conneally
authors.forename: S R
authors.initials: SR
authors.lastname: McCann
authors.forename: E
authors.initials: E
authors.lastname: Vandenberghe
authors.forename: P V
authors.initials: PV
authors.lastname: Browne
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000745:Anemia, Hemolytic, Congenital / Q000150:complications*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000628:therapy*; D008297:Male; D033581:Stem Cell Transplantation; D018183:Transplantation Chimera
chemical_list: D000305:Adrenal Cortex Hormones